POSTER SESSION VI
Wednesday, March 21, 2012 — 1:00 PM - 4:00 PM
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GENITOURINARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
132
Validation of New Staging System for Patients with Invasive Urothelial Carcinoma of the Prostate
(951)
R Miocinovic, AA El Latif, AJ Stephenson, D Hansel - Cleveland Clinic, Cleveland, OH
Argininosuccinate Synthetase Deficiency as a Possible Therapeutic Indicator for Pegylated Arginine Deiminase (ADI- PEG20) Therapy in Bladder Cancer
(877)
S Gupta, JS Bomalaski, PD Carver, DE Hansel - Cleveland Clinic, Cleveland; Polaris Group, San Diego
Differential Expression of SPINK1 in Urothelial Neoplasia: Clinical and Pathological Implications
(907)
KR Kawaguchi, K Park, A Chinnaiyan, M Loda, BD Robinson, R Lis, DS Scherr, JE Rosenberg, MA Rubin, JM Mosquera - Weill Cornell Medical College, New York, NY; University of Michigan, Ann Arbor, MI; Dana Farber Cancer Institute; Harvard Medical School, Boston, MA
Her2 Amplification Is Associated with a High Risk of Progression in Non-Muscle-Invasive Bladder Cancer
(971)
C-C Pan - Taipei Veterans General Hospital, Taipei, Taiwan
Immunohistochemical Expression of HER2 in Urothelial Carcinoma of the Bladder (UC): Comparison of the Breast Cancer (BC) and Gastric Cancer (GC) HER2 Scoring Systems
(1080)
B Zhu, X Lin, S Rohan, M Zhong, R Goyal, E Gersbach, X Yang - Northwestern University, Chicago
Expression of Androgen and Estrogen Receptors and Its Prognostic Significance in Urothelial Neoplasm of the Urinary Bladder
(953)
H Miyamoto, JL Yao, A Chaux, Q Yang, LA McMahon, Y Zheng, K Izumi, GJ Netto - University of Rochester, Rochester, NY; Johns Hopkins Medical Institution, Baltimore, MD
Histopathological Tumor Features Associated with Her2 Amplified Urothelial Bladder Cancers
(1033)
J Tschui, D Rotzer, R Seiler, A Fleischmann - Institute of Pathology, University of Berne, Berne, Switzerland; Department of Urology, University Hospital of Berne, Berne, Switzerland
E-Cadherin, Snail and Slug Expression in a Series of Non- Muscle Invasive Bladder Carcinomas with Long-Term Follow up
(1004)
R Santi, T Cai, M Pepi, M Paglierani, R Bartoletti, G Nesi - University of Florence, Florence, Italy; Santa Chiara Hospital, Trento, Italy
Ureteral and Urethral Margin Status in Radical Cystectomy Specimens
(923)
Z Kos, F Siadat, EC Belanger, BN Nguyen, KT Mai - The Ottawa Hospital and University of Ottawa, Ottawa, ON, Canada
Papillary Urothelial Neoplasm of Low Malignant Potential and Carcinoma with Extensive Urothelial ´Eddy´ Formation (pUNC-eUEF): A Distinct Morphologic Pattern with Low Risk for Progression
(916)
M-s Kim, JY Ro, YM Cho - University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea; The Methodist Hospital and Weill Medical College of Cornell University, Houston, TX
Long-Term Clinical Outcome of Inverted Urothelial Papilloma Including Cases with Focal Papillary Pattern: Is Continuous Surveillance Necessary?
(946)
JP Maxwell, C Wang, A Kulaga, A Yilmaz, K Trpkov - Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada
Construction of Prognostic Model Incorporating Biological Markers To Predict Progression of Non-Muscle-Invasive Bladder Cancer
(1069)
H-J Yu, C-C Pan - Cardinal Tien Hospital, New Taipei City, Taiwan; Taipei Veterans General Hospital, Taipei, Taiwan
Interstitial Cystitis, Another IgG4 Related Disease?
(860)
Y Ge, H Zhou, SS Shen, JY Ro - The Methodist Hospital, Weill Medical College of Cornell University, Houston, TX
Histopathological and Clinical Characterization of Intradiverticular Carcinoma in Urinary Bladder
(1075)
H Zhong, G Azabdaftari, B Xu - Roswell Park Cancer Institute, Buffalo, NY
Urethral Caruncle: Clinicopathologic Features of 41 Cases
(1059)
SR Williamson, MR Conces, R Montironi, A Lopez-Beltran, M Scarpelli, L Cheng - Indiana University School of Medicine, Indianapolis; Polytechnic University of the Marche Region (Ancona), Ancona, Italy; Cordoba University, Cordoba, Spain
The Spectrum of Histopathological Findings in Vesical Diverticulum: Implications for Pathogenesis and Staging
(895)
M Idrees, J Kum, A Riley, L Cheng - Indiana University, Indianapolis, IN
Reproducibility Assigning Grade in Noninvasive Papillary Urothelial Neoplasms among Dedicated Genitourinary Pathologists: A Single-Institution Study Based on the 2004 WHO Classification
(947)
R Mehra, A Amin, LL Gellert, A Gopalan, Y Chen, SW Fine, SK Tickoo, VE Reuter, H Al-Ahmadie - Memorial Sloan-Kettering Cancer Center, New York, NY
SPINK1 Expression in Bladder Urothelial Carcinoma In Situ: Important Clinical Implications
(910)
F Khani, K Park, Y-L Chiu, BD Robinson, MA Rubin, JM Mosquera - Weill Cornell Medical College, New York
Divergent Morphology in Renal Pelvic Urothelial Carcinoma May Be Less Frequent Than Previously Reported
(904)
C-S Kao, M Idrees - Indiana University, Indianapolis, IN
The Utility and Diagnostic Accuracy of Ureteroscopic Biopsy in Diagnosing Upper Urinary Tract Urothelial Carcinoma
(1042)
V Vashistha, DL Zynger - The Ohio State University Medical Center, Columbus, OH
Isolated Secondary Urothelial Dysplasia of the Bladder, a Clinicopathologic Characterization
(1064)
J-J Yang, E Diaz, D Hansel - Cleveland Clinic, Cleveland, OH
Pseudoangiosarcomatous (Acantholytic) Variant of Urothelial Carcinoma of the Urinary Bladder
(972)
GP Paner, RM Cox, M Large, AJ Cohn, N Gokden, ND Smith, T Krausz, JK McKenney, GD Steinberg - University of Chicago, Chicago, IL; University of Arkansas, Little Rock, AK; Standford University, Stanford, CA
Primary Clear Cell Adenocarcinoma of the Urethra: A Clinicopathologic Study of 16 Cases
(987)
P Rao, BA Czerniak, CC Guo - The University of Texas MD Anderson Cancer Center, Houston, TX
Value of Reflex ImmunoCyt Testing for the Diagnosis of Bladder Cancer
(797)
AB Berry, AY Odisho, AE Ahmad, MR Cooperberg, PR Carroll, BR Konety - University of California San Francisco, San Francisco, CA; University of Minnesota, Minneapolis, MN
Urine Cytology and Fluorescent In Situ Hybridization of Upper Urinary Tract Malignancies: A Report of Cases and Literature Review
(940)
CA Lum, C Gima, R Kaneshiro, E Matsubara, D Wei, R Maruyama, P Tauchi-Nishi - Queens Medical Center/Hawaii Pathologists Laboratory/ University of Hawaii, Honolulu, HI; Showa University Northern Yokohama Hospital, Yokohama, Japan; Queens Medical Center, Honolulu, HI; Shimane University, Izumo, Japan
DNA Mismatch Repair Deficiency in Urothelial Carcinoma: An Immunohistochemical Study in Upper Versus Lower Genitourinary Tract Tumors
(862)
LL Gellert, R Mehra, J Shia, Y Chen, A Gopalan, S Fine, S Tickoo, VE Reuter, H Al-Ahmadie - MSKCC, New York, NY
Smaller Prostate Size Is Associated with Greater Volume of Disease at Prostatectomy
(865)
B Gershman, F Dong, DM Dahl, FJ McGovern, NM Heney, WS McDougal, C-L Wu - Massachusetts General Hospital, Boston, MA
Finding of Prostate Carcinoma at the Capsular End of a Prostate Needle Biopsy Does Not Predict Positive Capsular Margin on Radical Prostatectomy Specimen
(795)
P Bernaczyk, R Milewski, L Chyczewski, J Kowalewska - Medical University of Bialystok, Bialystok, Poland
Metabolic Syndrome and Prostate Inflammation in Benign Prostate Hyperplasia
(1003)
R Santi, M Gacci, L Vignozzi, M Carini, M Maggi, G Nesi - University of Florence, Florence, Italy
Accuracy of Risk Assessment Tools To Predict EPE in Patients 45 Years Old or Younger with Prostate Cancer Treated by Radical Prostatectomy
(841)
SM Falzarano, E Walker, K Streator Smith, EA Klein, M Zhou, C Magi-Galluzzi - Cleveland Clinic, Cleveland; Cleveland Clinic, Cleveland, OH
Perinucleolar Clearing (PNC) with Macronucleoli Is Not a Feature of Some Benign Mimics of Prostate Cancer
(1002)
H Samaratunga, D Samaratunga, J Yaxley, J Perry Keene, D Payton, B Delahunt - Aquesta Pathology, Brisbane, QLD, Australia; Royal Brisbane Hospital, Brisbane, QLD, Australia; Wellington School of Medicine and Health Sciences, Wellington, Otago, New Zealand
Clinical and Pathologic Parameters Predicting Seminal Vesicle Invasion (SVI) Based on 12 Core Prostate Needle Biopsy Protocol
(1067)
JY Yoon, O Kryvenko, D Schultz, M Diaz Insua, N Gupta - Henry Ford Hospital, Detroit, MI
Perineural Invasion (PNI) in Prostate Cancer Patients Who Are Potential Candidates for Active Surveillance: A Validation Study
(1048)
C Wang, J Zhang, A Yilmaz, TA Bismar, K Trpkov - Calgary Laboratory Services and University of Calgary, Calgary, AB, Canada
Ductal Adenocarcinoma of the Prostate in 1051 Radical Prostatectomy Specimens. Histopathological Features and Prognostic Relevance
(1007)
A Seipel, F Wiklund, P Wiklund, L Egevad - Karolinska Institutet, Stockholm, Sweden
Close Surgical Margins after Radical Prostatectomy Are an Independent Predictor of Prostate Cancer Recurrent
(1061)
G Wirth, J Lu, S Wu, DM Dahl, AF Olumi, WS McDougal, RH Young, C-L Wu - Massachusetts General Hospital, Boston, MA
Application of ERG/TFF3/HMWCK Triple Immunostain: A Novel Diagnostic Biomarker in Prostate Needle Biopsies
(973)
K Park, F Demichelis, Y-L Chiu, MA Rubin, JM Mosquera - Weill Medical College of Cornell University, New York; University of Trento, Trento, Italy
High Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Intraductal Carcinoma of the Prostate (IDC-P):´Small Cell´ Variant
(931)
S Lee, JI Epstein - The Johns Hopkins Hospital, Baltimore
Comparison of Latent Prostate Cancer Detected at Autopsy between Pre- and Post-Prostatic Specific Antigen (PSA) Era
(967)
M Okayasu, H Takahashi, B Furusato, M Kido, S Mizukami, M Furusato, H Hano - The Jikei University School of Medicine, Minato-ku, Tokyo, Japan
Comparative Analysis of 12-Core Biopsy Results and Tumor Location in Prostatectomy Specimens
(979)
L Pelaez, V Iremashvili, M Jorda, M Manoharan, DL Rosenberg, MS Soloway - University of Miami, Miller School of Medicine, Miami, FL
An Evaluation of the Pathologic Reporting of Prostate Biopsy and Prostate Transurethral Resections with Urothelial Carcinoma
(846)
EJ Fichtenbaum, DL Zynger - The Ohio State University Medical Center, Columbus, OH
Individual Core Length, but Not Total Number of Cores or Total Core Length, Is Associated with Gleason Score Upgrading at Radical Prostatectomy in Patients Eligible for Active Surveillance
(908)
KR Kawaguchi, MP Herman, K Park, A Srivastava, AK Tewari, JM Mosquera, BD Robinson - Weill Cornell Medical College, New York
FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castrate Resistant Prostate Cancer
(959)
M Montani, J Gerhardt, G Kristiansen - University of Bern, Bern, Switzerland; University Hospital of Zurich, Zurich, Switzerland; University Hospital Bonn, Bonn, Germany
A Comparison of the Immunoexpression of ERG Versus AMACR, PSA and PSAP in Prostatic Carcinomas
(935)
DGS Lim, M Teh, TP Thamboo - National University Health System, Singapore
Prostate Cancer Field Effect: Common Gene Expression Alterations in Prostate Cancer and Benign Prostatic Tissue
(924)
F Kosari, CM Ida, J Karnes, SJ Murphy, G Vasmatzis, JC Cheville - Mayo Clinic, Rochester, MN
p16 Expression Is Not Associated with Human Papillomavirus (HPV) in Urinary Bladder Squamous Cell Carcinoma
(927)
JB Kum, Y Hu, R Montironi, A Lopez-Beltran, G Chen, GT MacLennan, MT Idrees, TM Ulbright, DG Grignon, JN Eble, L Cheng - Indiana University School of Medicine, Indianapolis, IN; Polytechnic Univeristy of the Marche Region (Ancona) United Hospitals, Ancona, Italy; Cordoba University, Cordoba, Spain; First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China; Case Western Reserve University, Cleveland, OH
button next to any title to add to Itinerary Planner...
Add
